文献速递毛发、甲与色素性疾病

CYP1B1与口服避孕药在额部纤维性脱发中的基因-环境交互作用

Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia.
PubMed 文献 · JAMA Dermatol · 2024-01-01

提示该变异的保护效应可能由OCP暴露介导。

要点

  • CYP1B1 c.1358A>G变异与FFA风险仅在有OCP使用史的女性中显著相关。
  • 无OCP暴露者中该变异与FFA无显著关联,提示OCP暴露修饰遗传效应。

核心结论

  • CYP1B1错义变异的保护效应可能由OCP暴露介导,OCP使用史修饰该变异与FFA风险的关联。

临床怎么用

  • 在评估女性FFA风险时,可关注OCP使用史与CYP1B1 c.1358A>G变异的联合效应,尤其对有OCP暴露史者。
  • 该发现有助于理解FFA的基因-环境交互机制,可能为风险分层提供依据,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Frontal fibrosing alopecia (FFA) is an increasingly prevalent form of follicular lichen planus, causing irreversible hair loss predominantly in postmenopausal individuals. An earlier genome-wide meta-analysis of female FFA identified risk loci in genes implicated in self-antigen presentation and T-cell homeostasis, including HLA-B*07:02, ST3GAL1, and SEMA4B. However, CYP1B1, which is important for hormone metabolism, was also implicated with the substitution of serine for asparagine at position 453 (c.1358A>G, p.Asn453Ser) exhibiting a protective effect against FFA. Increasing understanding of genetic and environmental variables and their interactions will improve understanding of disease pathogenesis and has the potential to inform risk mitigation strategies. OBJECTIVE: To investigate whether oral contraceptive pill (OCP) use modulates the protective effect of the common missense variant in CYP1B1 (c.1358A>G, p.Asn453Ser) on FFA risk. DESIGN, SETTING, AND PARTICIPANTS: This gene-environment interaction study using a case-control design enrolled female patients with FFA from UK-based dermatology clinics. The patients were matched with unrelated age- and ancestry-matched female control individuals derived from UK Biobank in a 1:66 ratio, determined by the first 4 principal components from genome-wide genotypes. Data were collected from July 2015 to September 2017, and analyzed from October 2022 to December 2023. MAIN OUTCOME AND MEASURE: The main outcomes were the modulatory effect of OCP use on the contribution of the CYP1B1 missense variant to female FFA risk and a formal gene-environment interaction test evaluated by a logistic regression model with a multiplicative interaction term, under the assumptions of an additive genetic model interaction term, under the assumptions of an additive genetic model. RESULTS: Of the 489 female patients with FFA, the mean (SD) age was 65.8 (9.7) years, and 370 (75.7%) had a history of OCP use. Of the 34 254 age- and ancestry-matched control individuals, the mean (SD) age was 65.0 (8.4) years, and previous OCP use was reported in 31 177 (91.0%). An association between female FFA and the CYP1B1 risk allele was observed in individuals who reported OCP use (odds ratio, 1.90 [95% CI, 1.50-2.40]; P = 8.41 × 10-8) but not in those with no documented exposure to OCPs (odds ratio, 1.16 [95% CI, 0.82-1.64]; P = .39). A full gene-environment interaction model demonstrated a significant additive statistical interaction between c.1358A, p.453Asn, and history of OCP use on FFA risk (OR for interaction, 1.63 [95% CI, 1.07-2.46]; P = .02). CONCLUSIONS AND RELEVANCE: This gene-environment interaction analysis suggests that the protective effect of the CYP1B1 missense variant on FFA risk might be mediated by exposure to OCPs. The allele that encodes an asparagine at position 453 of CYP1B1 was associated with increased odds of FFA only in participants with OCP history.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Rayinda T, McSweeney SM, Christou E, et al. Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia. JAMA Dermatol. 2024. PMID: 38809548. doi:10.1001/jamadermatol.2024.1315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。